MedPath

南京厚生药业有限公司

Ownership
-
Established
2003-07-08
Employees
-
Market Cap
-
Website
http://www.nj-lifecare.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

32

NMPA:32

Drug Approvals

Tinidazole Tablets

Product Name
替硝唑片
Approval Number
国药准字H20066408
Approval Date
Jan 29, 2021
NMPA

复方丹参片

Approval Number
国药准字Z20073080
Approval Date
Jan 29, 2021
NMPA

Tinidazole Capsules

Product Name
替硝唑胶囊
Approval Number
国药准字H20066536
Approval Date
Jan 29, 2021
NMPA

丹参片

Approval Number
国药准字Z20073081
Approval Date
Jan 29, 2021
NMPA

羚羊感冒胶囊

Approval Number
国药准字Z32020440
Approval Date
Jun 30, 2020
NMPA

垂盆草颗粒

Approval Number
国药准字Z32020477
Approval Date
Jun 30, 2020
NMPA

Cholestyramine Powder

Product Name
考来烯胺散
Approval Number
国药准字H10940130
Approval Date
Jun 30, 2020
NMPA

银翘解毒片

Approval Number
国药准字Z32020869
Approval Date
Jun 30, 2020
NMPA

Cholestyramine

Product Name
考来烯胺
Approval Number
国药准字H10940129
Approval Date
Jun 30, 2020
NMPA

救尔心胶囊

Approval Number
国药准字Z32020441
Approval Date
Jun 30, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.